These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 6005418

  • 1. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV.
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract] [Full Text] [Related]

  • 2. [Cause of hyperlipemia in nephrotic syndrome].
    Yoshitoshi Y, Naito C.
    Nihon Rinsho; 1968 May; 26(5):1106-16. PubMed ID: 4883020
    [No Abstract] [Full Text] [Related]

  • 3. [Semi-automatic colorimetric determination of fatty acids. Applications: determination of plasma free fatty acids, serum lipase and post-heparin plasma triglyceride-lipases].
    Fruchart JC, Dewailly P, Jaillard J, Sezille G.
    Ann Biol Clin (Paris); 1974 May; 32(3):237-44. PubMed ID: 4420932
    [No Abstract] [Full Text] [Related]

  • 4. Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and nephrotic syndrome.
    Gomperts ED, Zucker M, Feesey M, Russel D, Salant D, Joffe BI, Mendelsohn D, Seftel H.
    J Lab Clin Med; 1977 Sep; 90(3):529-35. PubMed ID: 578151
    [No Abstract] [Full Text] [Related]

  • 5. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E.
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [Abstract] [Full Text] [Related]

  • 6. Plasma lipoprotein lipase activity in primary type IV hyperlipoproteinaemia.
    Weir JJ, Cox D, Moore JH, Lawrie TD.
    Scott Med J; 1972 Jun; 17(6):214-6. PubMed ID: 5040092
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypertriglyceridemia. A metabolic consequence of chronic renal failure.
    Bagdade JD, Porte D, Bierman EL.
    N Engl J Med; 1968 Jul 25; 279(4):181-5. PubMed ID: 5658679
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Post-prandial lipoprotein metabolism in nephrotic syndrome.
    Warwick GL, Packard CJ, Stewart JP, Watson TD, Burns L, Boulton-Jones JM, Shepherd J.
    Eur J Clin Invest; 1992 Dec 25; 22(12):813-20. PubMed ID: 1478253
    [Abstract] [Full Text] [Related]

  • 11. [Study of plasma levels of free fatty acids and lipoprotein lipase activity in patients with nephrotic syndrome caused by intrinsic renal disease].
    de Faria CV, Diament J, Giannini SD.
    Rev Hosp Clin Fac Med Sao Paulo; 1973 Dec 25; 28(6):305-9. PubMed ID: 4767563
    [No Abstract] [Full Text] [Related]

  • 12. [Changes in post-heparin liprotein lipase activity after testosterone treatment].
    Pedini G, Perani G, Brambilla A, Zaietta P, Ranieri MC, Cotti L.
    G Clin Med; 1978 Dec 25; 59(5-6):199-209. PubMed ID: 689333
    [No Abstract] [Full Text] [Related]

  • 13. Lipoprotein lipase activity and hypertriglyceridemia in alloxan diabetic rabbits.
    O'Connor TP, Schnatz JD.
    Metabolism; 1968 Sep 25; 17(9):838-44. PubMed ID: 5674129
    [No Abstract] [Full Text] [Related]

  • 14. Astragalus mongholicus and Angelica sinensis compound alleviates nephrotic hyperlipidemia in rats.
    Li J, Yu L, Li N, Wang H.
    Chin Med J (Engl); 2000 Apr 25; 113(4):310-4. PubMed ID: 11775225
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of free fatty acids, lipoprotein lipase, and postheparin esterase in pregnancy.
    Fabian E, Stork A, Kucerová L, Sponarová J.
    Am J Obstet Gynecol; 1968 Apr 25; 100(7):904-7. PubMed ID: 5644301
    [No Abstract] [Full Text] [Related]

  • 16. [Plasmatic elimination of lipids and diabetes. Studies of lipoprotein lipase].
    Guisard D, Castro G, Debry G, Mullor JB.
    C R Seances Soc Biol Fil; 1972 Apr 25; 166(8):1067-70. PubMed ID: 4660171
    [No Abstract] [Full Text] [Related]

  • 17. Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome.
    Ongkingco JR, Mann WA, Ruley EJ, Gregg RE.
    Child Nephrol Urol; 1991 Apr 25; 11(2):107-10. PubMed ID: 1756519
    [Abstract] [Full Text] [Related]

  • 18. Hyperlipidemia of the nephrotic syndrome.
    Kaysen GA.
    Kidney Int Suppl; 1991 Apr 25; 31():S8-15. PubMed ID: 2046275
    [No Abstract] [Full Text] [Related]

  • 19. [Mutual relation between hyperlipidemia and nephrotic syndrome].
    Kraise Y, Averbuch M, Schwartz D, Kornovsky R, Levo Y.
    Harefuah; 1991 Dec 15; 121(12):521-4. PubMed ID: 1794760
    [No Abstract] [Full Text] [Related]

  • 20. Studies on the elimination of exogenous lipids from the blood stream. Effect of heparin on the elimination.
    Boberg J, Hallberg D.
    Acta Chir Scand; 1971 Dec 15; 137(8):749-55. PubMed ID: 5148853
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.